Wall Street Zen cut shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) from a hold rating to a sell rating in a research note released on Friday. Finally, TD Cowen initiated coverage on shares of Benitec Biopharma in a research note on Monday, July 7th. Get Benitec Biopharma alerts:View Our Latest Stock Report on BNTCBenitec Biopharma Trading Down 0.7%Shares of BNTC stock opened at $13.70 on Friday. Benitec Biopharma (NASDAQ:BNTC – Get Free Report) last announced its quarterly earnings results on Thursday, September 25th. Further ReadingReceive News & Ratings for Benitec Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Benitec Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.